FDA accepts for priority review a Bristol Myers Squibb supplemental BLA for Opdivo (nivolumab) plus Yervoy (ipilimumab) for a first-line treatment opt...
Drug compounding operations sue FDA in northern Texas federal court, seeking an order to reverse the agency decision last week to remove semaglutide (...
FDA rejects an Invivyd request to expand the existing emergency use authorization for pre-exposure prophylaxis of Covid-19 EUA for Pemgarda (pemivibar...
FDA says semaglutide injection product shortages (Novo Nordisks Wegovy and Ozempic) are resolved.
Pfizer discontinues the marketing of its hemophilia B gene therapy Beqvez (fidanacogene elaparvovec-dzkt) due to limited patient and physician interes...
FDA accepts for priority review a Boehringer Ingelheim NDA for zongertinib (BI 1810631) for treating certain adult patients with unresectable or metas...
FDA approves a Mirum Pharmaceuticals NDA for Ctexli (chenodiol) for treating adults with cerebrotendinous xanthomatosis.
Pharmaceutical Research and Manufacturers of America says FDA should revise its recommendations for sponsors requesting meetings concerning cellular a...
